Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis

This publication has 18 references indexed in Scilit:

• Relationship between intact 1–84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity
  American Journal of Kidney Diseases, 1995
• Aplastic osteodystrophy without aluminum: The role of “suppressed” parathyroid function
  Kidney International, 1993
• The spectrum of bone disease in end-stage renal failure—An evolving disorder
  Kidney International, 1993
• Phosphate Dialytic Removal: Enhancement of Phosphate Cellular Clearance by Biofiltration (with Acetate-Free Buffer Dialysate)
  Nephron, 1992
• Control of Hyperphosphatemia in Chronic Renal Failure
  Seminars in Dialysis, 1990
• The absorption of dietary phosphorus and calcium in hemodialysis patients
  Kidney International, 1986
• Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis
  New England Journal of Medicine, 1986
• Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis
  Kidney International, 1982
• METABOLIC STUDIES OF LOW PROTEIN DIETS IN UREMIA
  Medicine, 1973
• HYPERALUMINqMIA FROM ALUMINIUM RESINS IN RENAL FAILURE
  The Lancet, 1970